Drug Modalities
Technical Solutions
ESG
Newsroom
About Us
CN
Home/Newsroom/News

News 2024-12-19

Porton Newsletter | Q4 2024 Recap

Porton Expands GMP Manufacturing and New Modality Services in Shanghai Fengxian

Porton Successfully Hosts Ceremony for New Modality Capacity Upgrade

Drug Modalities: Innovative Services & Solutions from Porton Pharma


Click to Download

Others
More
Complex Antibody Therapies

News 2025-12-23

Porton&Nona: Strategic Partnership for Complex Antibody Therapy

Global biotech Nona partners with CDMO Porton to accelerate complex antibody drug development and commercialization.
Newsletter

News 2025-12-12

Porton Newsletter - November 2025 Recap

Technical Enabling Services & Solutions Company Events ESG Marketing Activities Others
Become part of Porton's community to access personalized insights and resources.
Subscribe for the Newsletter
Porton requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and our commitment to protecting your privacy, please review our Legal Disclaimer Terms and Porton Privacy.
US: (609) 860-1300
CN: (86) 23-8608-3200

ⓒ 2025 PORTON Legal Notices | Porton Privacy

This website provides information on products tailored for a diverse audience and may include product details or information that are not readily accessible or valid in your country. Please note that we do not accept any responsibility for accessing such information in a manner that may violate any legal processes, regulations, registrations, or usage guidelines in your country of origin.

Become part of Porton's community to access personalized insights and resources.
Submit
By clicking “Submit” you agree to our Legal Disclaimer terms and conditions and the Porton Privacy and Cookies Policy.

ⓒ 2025 PORTON Legal Notices | Porton Privacy

US: (609) 860-1300
CN: (86) 23-8608-3200